ParaGard TV Spot Misrepresents Contraceptive’s Risks, US FDA Says

 
• By Sue Sutter

‘Untitled’ letter is FDA's third in the past eighteen months to target promotions for women’s health products. In the case of advertisement for CooperSurgical's copper-containing intrauterine device, which is regulated as a drug, the agency took issue with distracting visuals and reliance on superimposed text.

Copper scrap bars and plates - Image
The copper in ParaGard gives the FDA’s Center for Drug Evaluation and Research jurisdiction over the IUD’s promotion. • Source: Shutterstock

More from Marketing & Advertising

More from Compliance